ProStrakan Pharma Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

ProStrakan Pharma General Information

Description

Developer of pharmaceutical products focusing on immune disorders. The company develops and markets pharmaceutical products in the therapeutic areas of oncology, hematology, neurology and supportive and intensive care.

Contact Information

Formerly Known As
OTL Pharma
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 231 Bureaux de la Colline
  • 92213 Saint Cloud
  • France
+33 01
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 231 Bureaux de la Colline
  • 92213 Saint Cloud
  • France
+33 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProStrakan Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ProStrakan Pharma‘s full profile, request access.

Request a free trial

ProStrakan Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProStrakan Pharma FAQs

  • When was ProStrakan Pharma founded?

    ProStrakan Pharma was founded in 1998.

  • Where is ProStrakan Pharma headquartered?

    ProStrakan Pharma is headquartered in Saint Cloud, France.

  • What is the size of ProStrakan Pharma?

    ProStrakan Pharma has 20 total employees.

  • What industry is ProStrakan Pharma in?

    ProStrakan Pharma’s primary industry is Drug Delivery.

  • Is ProStrakan Pharma a private or public company?

    ProStrakan Pharma is a Private company.

  • What is the current valuation of ProStrakan Pharma?

    The current valuation of ProStrakan Pharma is .

  • What is ProStrakan Pharma’s current revenue?

    The current revenue for ProStrakan Pharma is .

  • When was ProStrakan Pharma acquired?

    ProStrakan Pharma was acquired on 16-Jan-2004.

  • Who acquired ProStrakan Pharma?

    ProStrakan Pharma was acquired by Kyowa Kirin International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process